This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB06849/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB06849/identifier/pubchem-compound/
n12http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB06849/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB06849/identifier/drugbank/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB06849
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n12:DB06849 n13:DB06849
dcterms:title
1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine
adms:identifier
n7:DB06849 n8:99443320 n9:11N n10:25113124
n4:IUPAC-Name
n5:271B57E0-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B57E6-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B57E5-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B57E2-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B57E3-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B57E4-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B57DE-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B57DC-363D-11E5-9242-09173F13E4C5 n5:271B57DF-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B57DD-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B57EC-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B57ED-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B57E7-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B57E8-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B57EA-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B57E9-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B57EB-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B57F1-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B57F3-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B57F4-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B57F0-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B57EF-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B57F2-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B57E1-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B57EE-363D-11E5-9242-09173F13E4C5